| adrenergic receptor, alpha 1a | PERGOLIDE | Adrenergic alpha1A | 85% | 1.93uM | .781uM | View | 
          
            
                | adrenergic receptor, beta 3 | PINDOLOL | Adrenergic beta3 | 85% | .088uM | .066uM | View | 
          
            
                | androgen receptor | FLUOROMETHOLONE | Testosterone | 85% | 1.285uM | .857uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | PIPAMAZINE | Calcium Channel Type L, Phenylalkylamine | 85% | 1.941uM | 1.887uM | View | 
          
            
                | Protein-tyrosine kinase, Fyn | MICONAZOLE | Protein Tyrosine Kinase, Fyn | 85% | 4.16uM | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 3 | DEXCHLORPHENIRAMINE | Muscarinic M3 | 85% | 2.579uM | .547uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | DIETHYLSTILBESTROL | Serotonin 5-HT2A | 85% | 4.79uM | 1.369uM | View | 
          
            
                | progesterone receptor | DIETHYLSTILBESTROL | Progesterone | 85% | 4.682uM | .611uM | View | 
          
            
                | progesterone receptor | DIETHYLSTILBESTROL | Progesterone | 85% | 4.682uM | .611uM | View | 
          
            
                | progesterone receptor | ETHINYLESTRADIOL | Progesterone | 85% | 1.067uM | .139uM | View | 
          
            
                | progesterone receptor | ETHINYLESTRADIOL | Progesterone | 85% | 1.067uM | .139uM | View | 
          
            
                | insulin receptor | INSULIN | Insulin | 85% | .001932uM | .001816uM | View | 
          
            
                | insulin receptor | INSULIN | Insulin | 85% | .001932uM | .001816uM | View | 
          
            
                | solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 | RAPAMYCIN | Adenosine Transporter | 85% | 1.0848uM | .3711uM | View | 
          
            
                | concentrative Na+ nucleoside cotransporter (DBSS) | RAPAMYCIN | Adenosine Transporter | 85% | 1.0848uM | .3711uM | View | 
          
            
                | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 | RAPAMYCIN | Adenosine Transporter | 85% | 1.0848uM | .3711uM | View | 
          
            
                | adenine nucleotide translocase (DBSS) (Non-specific probe) | RAPAMYCIN | Adenosine Transporter | 85% | 1.0848uM | .3711uM | View | 
          
            
                | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | RAPAMYCIN | Adenosine Transporter | 85% | 1.0848uM | .3711uM | View | 
          
            
                | adrenergic receptor, alpha 2a | AMITRIPTYLINE | Imidazoline I2, Central | 85% | 1.685uM | 1.123uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | AMITRIPTYLINE | Imidazoline I2, Central | 85% | 1.685uM | 1.123uM | View | 
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | AMITRIPTYLINE | Adrenergic alpha1D | 85% | .105uM | .052uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | adrenergic receptor, alpha 2a | LISURIDE | Imidazoline I2, Central | 85% | .001606uM | .001071uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | LISURIDE | Imidazoline I2, Central | 85% | .001606uM | .001071uM | View | 
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | COBALT(II) ACETYLACETONATE | Protein Tyrosine Kinase, HER2 Receptor | 85% | 3.174uM | NoneNone | View | 
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | COBALT(II) ACETYLACETONATE | Protein Tyrosine Kinase, HER2 Receptor | 85% | 3.174uM | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | amiloride-sensitive cation channel 5, intestinal | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type VIII, alpha polypeptide | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type 10, alpha polypeptide | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha polypeptide | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha polypeptide | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 gamma | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, gamma | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, delta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type X, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage gated, type VIII, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type III, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel associated protein 1 | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel associated protein 2 | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | LISURIDE | Sodium Channel, Site 2 | 85% | 3.975uM | 3.627uM | View | 
          
            
                | opioid receptor, sigma 1 | PROMAZINE | Sigma1 | 85% | .271uM | .114uM | View | 
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | NITRENDIPINE | CYP450-2C9 Inhibition | 85% | .3uM | NoneNone | View | 
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | NITRENDIPINE | CYP450-2C9 Inhibition | 85% | .3uM | NoneNone | View | 
          
            
                | dopamine receptor D1A | PROMAZINE | Dopamine D1 | 85% | 2.464uM | 1.232uM | View | 
          
            
                | dopamine receptor D1A | NELFINAVIR | Dopamine D1 | 85% | 12.935uM | 6.467uM | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | amiloride-sensitive cation channel 5, intestinal | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type VIII, alpha polypeptide | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type 10, alpha polypeptide | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha polypeptide | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha polypeptide | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 gamma | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 beta | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, gamma | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, delta | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | PAROXETINE | Sodium Channel, Site 2 | 85% | 2.69uM | 2.454uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H, member 8 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 6 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 7 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 2 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 5 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 3 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 4 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | DROPERIDOL | Potassium Channel HERG | 85% | .9272uM | .7596uM | View | 
          
            
                | androgen receptor | HEXACHLOROPHENE | Testosterone | 85% | 4.9753uM | 3.3169uM | View | 
          
            
                | carbonic anhydrase 5a, mitochondrial | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase 3 | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase 2 | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase 4 | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase XI | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase IX | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase VIII | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase VII | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase VA, mitochondrial | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase IV | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase III, muscle specific | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase I | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase XIV | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase VB, mitochondrial | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase XII | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase VI | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | carbonic anhydrase II | ZINC CHLORIDE | Carbonic Anhydrase | 85% | 1.159uM | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | VALETHAMATE BROMIDE | CYP450-2D6 Inhibition | 85% | .2485uM | NoneNone | View | 
          
            
                | thromboxane A synthase 1 | ZAFIRLUKAST | Thromboxane Synthetase | 85% | 3.81uM | NoneNone | View | 
          
            
                | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | ZAFIRLUKAST | Thromboxane Synthetase | 85% | 3.81uM | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | CINNARIZINE | Serotonin 5-HT1A | 85% | 1.083uM | .619uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | DILTIAZEM | Calcium Channel Type L, Phenylalkylamine | 85% | .63uM | .612uM | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | LABETALOL | CYP450-2D6 Inhibition | 85% | .8uM | NoneNone | View | 
          
            
                | Cytochrom P450-2C19 monooxygenase | PHENYLHYDRAZINE | CYP450-2C19 Inhibition | 85% | 5uM | NoneNone | View | 
          
            
                | A3 adenosine receptor | IODOQUINOL | Adenosine A3 | 85% | .933uM | .527uM | View | 
          
            
                | phosphodiesterase 3B | BITHIONOL | Phosphodiesterase PDE3 | 85% | 2.723uM | NoneNone | View | 
          
            
                | phosphodiesterase 3A | BITHIONOL | Phosphodiesterase PDE3 | 85% | 2.723uM | NoneNone | View | 
          
            
                | dopamine receptor D3 | BITHIONOL | Dopamine D3 | 85% | 4.218uM | 1.433uM | View | 
          
            
                | acetylcholinesterase (YT blood group) | ETHYLESTRENOL | Acetylcholinesterase | 85% | 6.504uM | NoneNone | View | 
          
            
                | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | ETHYLESTRENOL | Acetylcholinesterase | 85% | 6.504uM | NoneNone | View | 
          
            
                | acetylcholinesterase | ETHYLESTRENOL | Acetylcholinesterase | 85% | 6.504uM | NoneNone | View | 
          
            
                | synaptic vesicle glycoprotein 2b | FENBENDAZOLE | beta-Lactamase | 85% | 5.994uM | NoneNone | View | 
          
            
                | Sigma-2 Receptor | BENZTROPINE | Sigma2 | 85% | .183uM | .112uM | View | 
          
            
                | adrenergic receptor, alpha 2a | BENZTROPINE | Imidazoline I2, Central | 85% | 1.925uM | 1.284uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | BENZTROPINE | Imidazoline I2, Central | 85% | 1.925uM | 1.284uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | OXYMETAZOLINE | Calcium Channel Type L, Phenylalkylamine | 84% | 2.246uM | 2.184uM | View | 
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | CADMIUM CHLORIDE | Protein Tyrosine Kinase, HER2 Receptor | 84% | 1.334uM | NoneNone | View | 
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | CADMIUM CHLORIDE | Protein Tyrosine Kinase, HER2 Receptor | 84% | 1.334uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | LACIDIPINE | Calcium Channel Type L, Benzothiazepine | 84% | .005449uM | .004843uM | View |